Answers are grounded in this paper and cite their sources.
This report describes similar early safety findings from the Vaccine Adverse Event Reporting System for bivalent booster vaccination in children aged 5–11 years as the monovalent booster vaccination.
No takes yet. Share an insight, caveat, or question.
Hause et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: